{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:39Z","timestamp":1793374239341,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/rlu.0000000000001718","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T16:57:24Z","timestamp":1497113844000},"page":"595-602","source":"Crossref","is-referenced-by-count":35,"title":["Multicenter Comparison of Contrast-Enhanced FDG PET\/CT and 64-Slice Multi\u2013Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Nieves","family":"G\u00f3mez Le\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto C.","family":"Delgado-Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"del Campo del Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyes","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena","family":"Cannata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saturnino","family":"Gonz\u00e1lez Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa \u00c1ngeles","family":"P\u00e9rez S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"L\u00f3pez-Botet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Rodr\u00edguez-Vigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.semnuclmed.2005.02.003","article-title":"Initial staging of lymphoma with positron emission tomography and computed tomography","volume":"35","author":"Hicks","year":"2005","journal-title":"Semin Nucl Med"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2007-07-101899","article-title":"Imaging in staging of malignant lymphoma: a systematic review","volume":"111","author":"Kwee","year":"2008","journal-title":"Blood"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1055\/s-0028-1109509","article-title":"RECIST and WHO criteria evaluation of cervical, thoracic and abdominal lymph nodes in patients with malignant lymphoma: manual versus semi-automated measurement on standard MDCT slices","volume":"181","author":"Keil","year":"2009","journal-title":"Rofo"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra050276","article-title":"Positron-emission tomography and assessment of cancer therapy","volume":"354","author":"Juweid","year":"2006","journal-title":"N Engl J Med"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1007\/s00259-003-1169-2","article-title":"Limitations of PET for imaging lymphoma","volume":"30","author":"Barrington","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","author":"Elstrom","year":"2003","journal-title":"Blood"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rcl.2007.05.006","article-title":"Normal and abnormal patterns of FDG-PET\/CT in lymphoma","volume":"45","author":"Bar-Shalom","year":"2007","journal-title":"Radiol Clin N Am"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiol.2323030985","article-title":"Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging\u2014do we need contrast enhanced CT?","volume":"232","author":"Schaefer","year":"2004","journal-title":"Radiology"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1148\/radiol.2373040555","article-title":"Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience","volume":"237","author":"Tatsumi","year":"2005","journal-title":"Radiology"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00259-006-0171-x","article-title":"Value of PET\/CT versus PET and CT performed as separate investigations in patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma","volume":"33","author":"La Foug\u00e8re","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mibio.2004.08.004","article-title":"Comparison between 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography and positron emission tomography\/computed tomography hardware fusion for staging of patients with lymphoma","volume":"6","author":"Allen-Auerbach","year":"2004","journal-title":"Mol Imaging Biol"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","article-title":"Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era?","volume":"17","author":"Raanani","year":"2006","journal-title":"Ann Oncol"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06284.x","article-title":"Positron emission tomography\/computed tomography: diagnostic accuracy in lymphoma","volume":"135","author":"Hern\u00e1ndez-Maraver","year":"2006","journal-title":"Br J Haematol"},{"key":"R17-4-20210204","first-page":"1643","article-title":"PET\/CT in lymphoma: prospective study of enhanced full-dose PET\/CT versus unenhanced low-dose PET\/CT","volume":"47","author":"Rodr\u00edguez-Vigil","year":"2006","journal-title":"J Nucl Med"},{"key":"R18-4-20210204","first-page":"181","article-title":"Integrated FDG PET\/CT: utility and applications in clinical oncology","volume":"2","author":"Pinilla","year":"2008","journal-title":"Clin Med Oncol"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/annonc\/mdn282","article-title":"Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma","volume":"19","author":"Elstrom","year":"2008","journal-title":"Ann Oncol"},{"key":"R20-4-20210204","first-page":"567","article-title":"Diagnostic value of CT, PET and combined PET\/CT performed with low-dose unenhanced CT and full dose enhanced CT in the initial staging of lymphoma","volume":"55","author":"Pinilla","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2013.103218","article-title":"The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale","volume":"99","author":"Gallamini","year":"2014","journal-title":"Haematologica"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00259-016-3390-9","article-title":"Diagnostic accuracy of FDG PET\/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC)","volume":"43","author":"Fallanca","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-4-20210204","first-page":"601","article-title":"Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin\u2019s lymphoma","volume":"42","author":"Tatsumi","year":"2001","journal-title":"J Nucl Med"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R28-4-20210204","first-page":"1361","article-title":"Response evaluation with total lesion glycolysis in patients with malignant lymphoma: comparison to SULpeak in PERCIST on 18F-FDG PET\/CT study","volume":"53","author":"Tadashi","year":"2012","journal-title":"J Nucl Med"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00330-009-1685-y","article-title":"RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline","volume":"20","author":"van Persijn van Meerten","year":"2010","journal-title":"Eur Radiol"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1157\/13112510","article-title":"The value of positron emission tomography\/computed tomography (PET\/CT) in the staging of diffuse large B-cell lymphoma","volume":"129","author":"Fuertes","year":"2007","journal-title":"Med Clin (Barc"},{"key":"R31-4-20210204","first-page":"958","article-title":"18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis","volume":"46","author":"Pakos","year":"2005","journal-title":"J Nucl Med"},{"key":"R32-4-20210204","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3109\/10428194.2016.1140162","article-title":"Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography versus bone marrow biopsy","volume":"57","author":"Gheysens","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"R33-4-20210204","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0284185114554824","article-title":"Direct comparison of visual and quantitative bone marrow FDG-PET\/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET\/CT live up to its promise?","volume":"56","author":"Adams","year":"2015","journal-title":"Acta Radiol"},{"key":"R34-4-20210204","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1007\/s00330-016-4365-8","article-title":"Clinical significance of post-treatment 18F-fluorodeoxyglucose uptake in cervical lymph nodes in patients with diffuse large B-cell lymphoma","volume":"26","author":"An","year":"2016","journal-title":"Eur Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:19:18Z","timestamp":1620973158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201708000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001718","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}